Latest Insider Transactions at Revance Therapeutics, Inc. (RVNC)
This section provides a real-time view of insider transactions for Revance Therapeutics, Inc. (RVNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revance Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revance Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.51%
|
$2,000
$2.18 P/Share
|
|
Jun 30
2024
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.1%
|
$2,000
$2.18 P/Share
|
|
May 01
2024
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+24.96%
|
-
|
|
May 01
2024
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+32.22%
|
-
|
|
May 01
2024
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.59%
|
-
|
|
May 01
2024
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+22.55%
|
-
|
|
May 01
2024
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+32.14%
|
-
|
|
May 01
2024
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.59%
|
-
|
|
May 01
2024
|
Vlad Coric Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+41.92%
|
-
|
|
Apr 16
2024
|
Erica Jordan Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,392
-2.04%
|
$7,176
$3.8 P/Share
|
|
Mar 18
2024
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
8,125
-5.57%
|
$40,625
$5.04 P/Share
|
|
Mar 18
2024
|
Dustin S Sjuts President |
SELL
Open market or private sale
|
Direct |
9,211
-5.21%
|
$46,055
$5.04 P/Share
|
|
Mar 18
2024
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
9,361
-4.63%
|
$46,805
$5.04 P/Share
|
|
Mar 15
2024
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,269
-2.19%
|
$16,345
$5.3 P/Share
|
|
Mar 15
2024
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,967
-1.65%
|
$14,835
$5.3 P/Share
|
|
Mar 15
2024
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,533
-1.01%
|
$102,665
$5.3 P/Share
|
|
Mar 15
2024
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,822
-1.86%
|
$19,110
$5.3 P/Share
|
|
Mar 06
2024
|
Mark J Foley CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+2.87%
|
$180,000
$6.98 P/Share
|
|
Feb 29
2024
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
22,110
+10.95%
|
-
|
|
Feb 29
2024
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
15,143
+9.21%
|
-
|
|
Feb 29
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,447
+7.81%
|
-
|
|
Feb 29
2024
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
70,750
+6.7%
|
-
|
|
Jan 31
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
96,667
+33.91%
|
-
|
|
Jan 31
2024
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+40.17%
|
-
|
|
Dec 31
2023
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.17%
|
$1,848
$7.47 P/Share
|
|
Dec 31
2023
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
264
+0.03%
|
$1,848
$7.47 P/Share
|
|
Dec 31
2023
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
434
+0.47%
|
$3,038
$7.47 P/Share
|
|
Dec 15
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,712
-2.91%
|
$37,696
$8.08 P/Share
|
|
Sep 06
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
11,000
-19.98%
|
$187,000
$17.06 P/Share
|
|
Sep 05
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
23,853
-30.22%
|
$405,501
$17.81 P/Share
|
|
Aug 11
2023
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,064
-4.99%
|
$865,152
$18.91 P/Share
|
|
Aug 11
2023
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
122,143
+11.26%
|
-
|
|
Aug 11
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
8,901
-5.21%
|
$160,218
$18.91 P/Share
|
|
Aug 11
2023
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+11.68%
|
-
|
|
Aug 11
2023
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,592
-10.84%
|
$172,656
$18.91 P/Share
|
|
Aug 11
2023
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
19,346
+17.94%
|
-
|
|
Aug 11
2023
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,215
-10.94%
|
$201,870
$18.91 P/Share
|
|
Aug 11
2023
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
22,620
+18.08%
|
-
|
|
Aug 03
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
26,279
-3.03%
|
$578,138
$22.57 P/Share
|
|
Jul 03
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
26,279
-2.94%
|
$630,696
$24.94 P/Share
|
|
Jul 03
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
1,701
-2.08%
|
$42,525
$25.04 P/Share
|
|
Jun 30
2023
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.11%
|
$15,000
$15.61 P/Share
|
|
Jun 30
2023
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.67%
|
$15,000
$15.61 P/Share
|
|
Jun 30
2023
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
769
+0.93%
|
$11,535
$15.61 P/Share
|
|
Jun 15
2023
|
Carey O Connor Kolaja Director |
SELL
Open market or private sale
|
Direct |
2,500
-13.12%
|
$70,000
$28.24 P/Share
|
|
Jun 15
2023
|
Carey O Connor Kolaja Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+11.6%
|
$45,000
$18.12 P/Share
|
|
Jun 09
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
31,279
-3.39%
|
$938,370
$30.72 P/Share
|
|
Jun 09
2023
|
Dustin S Sjuts President |
SELL
Open market or private sale
|
Direct |
5,000
-3.28%
|
$150,000
$30.82 P/Share
|
|
Jun 02
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
500
-0.61%
|
$15,500
$31.0 P/Share
|
|
Jun 01
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
2,701
-3.21%
|
$81,030
$30.57 P/Share
|